Quote | Super Quote
Future News

02/10/2026 09:18

Wei Jun Biotechnology (00660) Delays Publication of Full-Year Results, Suspends Trading This Morning

    HONG KONG ECONOMY TODAY NEWS (September 2) — Wei Jun Biotechnology (00660) announced that due to the company and its auditor requiring additional time to complete the audit work, it is unable to publish the annual results for the year ended June 30 by September 30. The company's shares are expected to be suspended from trading starting at 9 a.m. today.
  
    The company is closely cooperating with the auditor, providing required information and documents to complete the audit process as soon as possible. However, the expected publication date for the full-year results still needs further discussion and confirmation. The board confirms that the company continues to operate normally and its business operations are unaffected.

    The board believes it is inappropriate at this stage to publish unaudited management accounts, as such accounts may not accurately reflect the group's financial performance or position and could mislead investors and shareholders.

    Due to the delayed publication of the full-year results, the annual report, originally required to be dispatched by October 31, may also be delayed. If the delay is confirmed, it will constitute a breach of Rule 13.46(2) of the Listing Rules. The company will make a separate announcement regarding the expected dispatch date and related progress. (eh)
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.